Skip to main content
. 2021 Feb 1;9(2):138. doi: 10.3390/biomedicines9020138

Figure 4.

Figure 4

This depicts the various strategies adopted in the engineering of oncolytic viruses to grant selective tropism for malignant cells. The image was adapted from Groeneveldt et al., Trends Immunol 2020.